Daniel Atchley

Daniel Atchley is a Professor of Pharmaceutical Sciences at Harding University's College of Pharmacy. His research focuses on novel antimicrobial agents and clinical pharmacology, particularly involving hormonal effects and bone metabolism. He holds a PhD in Basic Sciences from the Medical University of South Carolina, an MT-ASCP in Medical Technology from Northeastern State University, and an MS in Laboratory Medicine from the University of Washington.

His recent work includes a 2019 study on exemestane's impact on osteoprotegerin concentration in postmenopausal women, published in The Journal of Clinical Pharmacology. While no awards or grants are explicitly listed, his research bridges clinical drug studies with endocrinological outcomes. No advising roles or student supervision details are provided in the text.